1 Study Coverage
1.1 Brompheniramine Product Introduction
1.2 Market by Type
1.2.1 Global Brompheniramine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Solution
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Brompheniramine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Brompheniramine Sales Estimates and Forecasts 2017-2028
2.2 Global Brompheniramine Revenue Estimates and Forecasts 2017-2028
2.3 Global Brompheniramine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Brompheniramine Sales by Region
2.4.1 Global Brompheniramine Sales by Region (2017-2022)
2.4.2 Global Sales Brompheniramine by Region (2023-2028)
2.5 Global Brompheniramine Revenue by Region
2.5.1 Global Brompheniramine Revenue by Region (2017-2022)
2.5.2 Global Brompheniramine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Brompheniramine Sales by Manufacturers
3.1.1 Global Top Brompheniramine Manufacturers by Sales (2017-2022)
3.1.2 Global Brompheniramine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brompheniramine in 2021
3.2 Global Brompheniramine Revenue by Manufacturers
3.2.1 Global Brompheniramine Revenue by Manufacturers (2017-2022)
3.2.2 Global Brompheniramine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Brompheniramine Revenue in 2021
3.3 Global Brompheniramine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Brompheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Brompheniramine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brompheniramine Sales by Type
4.1.1 Global Brompheniramine Historical Sales by Type (2017-2022)
4.1.2 Global Brompheniramine Forecasted Sales by Type (2023-2028)
4.1.3 Global Brompheniramine Sales Market Share by Type (2017-2028)
4.2 Global Brompheniramine Revenue by Type
4.2.1 Global Brompheniramine Historical Revenue by Type (2017-2022)
4.2.2 Global Brompheniramine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Brompheniramine Revenue Market Share by Type (2017-2028)
4.3 Global Brompheniramine Price by Type
4.3.1 Global Brompheniramine Price by Type (2017-2022)
4.3.2 Global Brompheniramine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Brompheniramine Sales by Application
5.1.1 Global Brompheniramine Historical Sales by Application (2017-2022)
5.1.2 Global Brompheniramine Forecasted Sales by Application (2023-2028)
5.1.3 Global Brompheniramine Sales Market Share by Application (2017-2028)
5.2 Global Brompheniramine Revenue by Application
5.2.1 Global Brompheniramine Historical Revenue by Application (2017-2022)
5.2.2 Global Brompheniramine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Brompheniramine Revenue Market Share by Application (2017-2028)
5.3 Global Brompheniramine Price by Application
5.3.1 Global Brompheniramine Price by Application (2017-2022)
5.3.2 Global Brompheniramine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Brompheniramine Market Size by Type
6.1.1 North America Brompheniramine Sales by Type (2017-2028)
6.1.2 North America Brompheniramine Revenue by Type (2017-2028)
6.2 North America Brompheniramine Market Size by Application
6.2.1 North America Brompheniramine Sales by Application (2017-2028)
6.2.2 North America Brompheniramine Revenue by Application (2017-2028)
6.3 North America Brompheniramine Market Size by Country
6.3.1 North America Brompheniramine Sales by Country (2017-2028)
6.3.2 North America Brompheniramine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Brompheniramine Market Size by Type
7.1.1 Europe Brompheniramine Sales by Type (2017-2028)
7.1.2 Europe Brompheniramine Revenue by Type (2017-2028)
7.2 Europe Brompheniramine Market Size by Application
7.2.1 Europe Brompheniramine Sales by Application (2017-2028)
7.2.2 Europe Brompheniramine Revenue by Application (2017-2028)
7.3 Europe Brompheniramine Market Size by Country
7.3.1 Europe Brompheniramine Sales by Country (2017-2028)
7.3.2 Europe Brompheniramine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Brompheniramine Market Size by Type
8.1.1 Asia Pacific Brompheniramine Sales by Type (2017-2028)
8.1.2 Asia Pacific Brompheniramine Revenue by Type (2017-2028)
8.2 Asia Pacific Brompheniramine Market Size by Application
8.2.1 Asia Pacific Brompheniramine Sales by Application (2017-2028)
8.2.2 Asia Pacific Brompheniramine Revenue by Application (2017-2028)
8.3 Asia Pacific Brompheniramine Market Size by Region
8.3.1 Asia Pacific Brompheniramine Sales by Region (2017-2028)
8.3.2 Asia Pacific Brompheniramine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Brompheniramine Market Size by Type
9.1.1 Latin America Brompheniramine Sales by Type (2017-2028)
9.1.2 Latin America Brompheniramine Revenue by Type (2017-2028)
9.2 Latin America Brompheniramine Market Size by Application
9.2.1 Latin America Brompheniramine Sales by Application (2017-2028)
9.2.2 Latin America Brompheniramine Revenue by Application (2017-2028)
9.3 Latin America Brompheniramine Market Size by Country
9.3.1 Latin America Brompheniramine Sales by Country (2017-2028)
9.3.2 Latin America Brompheniramine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Brompheniramine Market Size by Type
10.1.1 Middle East and Africa Brompheniramine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Brompheniramine Revenue by Type (2017-2028)
10.2 Middle East and Africa Brompheniramine Market Size by Application
10.2.1 Middle East and Africa Brompheniramine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Brompheniramine Revenue by Application (2017-2028)
10.3 Middle East and Africa Brompheniramine Market Size by Country
10.3.1 Middle East and Africa Brompheniramine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Brompheniramine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AMAG Pharmaceuticals
11.2.1 AMAG Pharmaceuticals Corporation Information
11.2.2 AMAG Pharmaceuticals Overview
11.2.3 AMAG Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AMAG Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AMAG Pharmaceuticals Recent Developments
11.3 PAI
11.3.1 PAI Corporation Information
11.3.2 PAI Overview
11.3.3 PAI Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 PAI Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PAI Recent Developments
11.4 USL Pharma
11.4.1 USL Pharma Corporation Information
11.4.2 USL Pharma Overview
11.4.3 USL Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 USL Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 USL Pharma Recent Developments
11.5 Watson Laboratories
11.5.1 Watson Laboratories Corporation Information
11.5.2 Watson Laboratories Overview
11.5.3 Watson Laboratories Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Watson Laboratories Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Watson Laboratories Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Ivax Pharmaceuticals
11.7.1 Ivax Pharmaceuticals Corporation Information
11.7.2 Ivax Pharmaceuticals Overview
11.7.3 Ivax Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ivax Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ivax Pharmaceuticals Recent Developments
11.8 Newtron Pharmaceuticals
11.8.1 Newtron Pharmaceuticals Corporation Information
11.8.2 Newtron Pharmaceuticals Overview
11.8.3 Newtron Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Newtron Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Newtron Pharmaceuticals Recent Developments
11.9 Nexgen Pharma
11.9.1 Nexgen Pharma Corporation Information
11.9.2 Nexgen Pharma Overview
11.9.3 Nexgen Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Nexgen Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nexgen Pharma Recent Developments
11.10 Endo International
11.10.1 Endo International Corporation Information
11.10.2 Endo International Overview
11.10.3 Endo International Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Endo International Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Endo International Recent Developments
11.11 Novartis
11.11.1 Novartis Corporation Information
11.11.2 Novartis Overview
11.11.3 Novartis Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Recent Developments
11.12 Eon Pharma
11.12.1 Eon Pharma Corporation Information
11.12.2 Eon Pharma Overview
11.12.3 Eon Pharma Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Eon Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eon Pharma Recent Developments
11.13 Merck
11.13.1 Merck Corporation Information
11.13.2 Merck Overview
11.13.3 Merck Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Merck Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Merck Recent Developments
11.14 Tanta Pharmaceuticals
11.14.1 Tanta Pharmaceuticals Corporation Information
11.14.2 Tanta Pharmaceuticals Overview
11.14.3 Tanta Pharmaceuticals Brompheniramine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tanta Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tanta Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brompheniramine Industry Chain Analysis
12.2 Brompheniramine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brompheniramine Production Mode & Process
12.4 Brompheniramine Sales and Marketing
12.4.1 Brompheniramine Sales Channels
12.4.2 Brompheniramine Distributors
12.5 Brompheniramine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Brompheniramine Industry Trends
13.2 Brompheniramine Market Drivers
13.3 Brompheniramine Market Challenges
13.4 Brompheniramine Market Restraints
14 Key Findings in The Global Brompheniramine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Brompheniramine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Solution
Table 3. Major Manufacturers of Tablet
Table 4. Global Brompheniramine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Brompheniramine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Brompheniramine Sales by Region (2017-2022) & (K Units)
Table 7. Global Brompheniramine Sales Market Share by Region (2017-2022)
Table 8. Global Brompheniramine Sales by Region (2023-2028) & (K Units)
Table 9. Global Brompheniramine Sales Market Share by Region (2023-2028)
Table 10. Global Brompheniramine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Brompheniramine Revenue Market Share by Region (2017-2022)
Table 12. Global Brompheniramine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Brompheniramine Revenue Market Share by Region (2023-2028)
Table 14. Global Brompheniramine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Brompheniramine Sales Share by Manufacturers (2017-2022)
Table 16. Global Brompheniramine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Brompheniramine Revenue Share by Manufacturers (2017-2022)
Table 18. Brompheniramine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Brompheniramine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Brompheniramine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brompheniramine as of 2021)
Table 21. Brompheniramine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Brompheniramine Product Offered
Table 23. Date of Manufacturers Enter into Brompheniramine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 26. Global Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 27. Global Brompheniramine Sales Share by Type (2017-2022)
Table 28. Global Brompheniramine Sales Share by Type (2023-2028)
Table 29. Global Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Brompheniramine Revenue Share by Type (2017-2022)
Table 32. Global Brompheniramine Revenue Share by Type (2023-2028)
Table 33. Brompheniramine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Brompheniramine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 36. Global Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 37. Global Brompheniramine Sales Share by Application (2017-2022)
Table 38. Global Brompheniramine Sales Share by Application (2023-2028)
Table 39. Global Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Brompheniramine Revenue Share by Application (2017-2022)
Table 42. Global Brompheniramine Revenue Share by Application (2023-2028)
Table 43. Brompheniramine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Brompheniramine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 46. North America Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 47. North America Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 50. North America Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 51. North America Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Brompheniramine Sales by Country (2017-2022) & (K Units)
Table 54. North America Brompheniramine Sales by Country (2023-2028) & (K Units)
Table 55. North America Brompheniramine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Brompheniramine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Brompheniramine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Brompheniramine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Brompheniramine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Brompheniramine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Brompheniramine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Brompheniramine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Brompheniramine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Brompheniramine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Brompheniramine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Brompheniramine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Brompheniramine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Brompheniramine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Brompheniramine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Brompheniramine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Brompheniramine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Brompheniramine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Brompheniramine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Brompheniramine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Brompheniramine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Brompheniramine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Brompheniramine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Brompheniramine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Brompheniramine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Brompheniramine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Pfizer Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. AMAG Pharmaceuticals Corporation Information
Table 111. AMAG Pharmaceuticals Description and Major Businesses
Table 112. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. AMAG Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AMAG Pharmaceuticals Recent Developments
Table 115. PAI Corporation Information
Table 116. PAI Description and Major Businesses
Table 117. PAI Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. PAI Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. PAI Recent Developments
Table 120. USL Pharma Corporation Information
Table 121. USL Pharma Description and Major Businesses
Table 122. USL Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. USL Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. USL Pharma Recent Developments
Table 125. Watson Laboratories Corporation Information
Table 126. Watson Laboratories Description and Major Businesses
Table 127. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Watson Laboratories Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Watson Laboratories Recent Developments
Table 130. Teva Corporation Information
Table 131. Teva Description and Major Businesses
Table 132. Teva Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Teva Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Teva Recent Developments
Table 135. Ivax Pharmaceuticals Corporation Information
Table 136. Ivax Pharmaceuticals Description and Major Businesses
Table 137. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Ivax Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Ivax Pharmaceuticals Recent Developments
Table 140. Newtron Pharmaceuticals Corporation Information
Table 141. Newtron Pharmaceuticals Description and Major Businesses
Table 142. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Newtron Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Newtron Pharmaceuticals Recent Developments
Table 145. Nexgen Pharma Corporation Information
Table 146. Nexgen Pharma Description and Major Businesses
Table 147. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Nexgen Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Nexgen Pharma Recent Developments
Table 150. Endo International Corporation Information
Table 151. Endo International Description and Major Businesses
Table 152. Endo International Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Endo International Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Endo International Recent Developments
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Major Businesses
Table 157. Novartis Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Novartis Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Novartis Recent Developments
Table 160. Eon Pharma Corporation Information
Table 161. Eon Pharma Description and Major Businesses
Table 162. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Eon Pharma Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Eon Pharma Recent Developments
Table 165. Merck Corporation Information
Table 166. Merck Description and Major Businesses
Table 167. Merck Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Merck Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Merck Recent Developments
Table 170. Tanta Pharmaceuticals Corporation Information
Table 171. Tanta Pharmaceuticals Description and Major Businesses
Table 172. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Tanta Pharmaceuticals Brompheniramine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Tanta Pharmaceuticals Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Brompheniramine Distributors List
Table 178. Brompheniramine Customers List
Table 179. Brompheniramine Market Trends
Table 180. Brompheniramine Market Drivers
Table 181. Brompheniramine Market Challenges
Table 182. Brompheniramine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Brompheniramine Product Picture
Figure 3. Global Brompheniramine Market Share by Type in 2021 & 2028
Figure 3. Oral Solution Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Brompheniramine Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Brompheniramine Report Years Considered
Figure 9. Global Brompheniramine Sales 2017-2028 (K Units)
Figure 10. Global Brompheniramine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Brompheniramine Revenue 2017-2028 (US$ Million)
Figure 12. Global Brompheniramine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Brompheniramine Sales Market Share by Region (2017-2022)
Figure 14. Global Brompheniramine Sales Market Share by Region (2023-2028)
Figure 15. North America Brompheniramine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Brompheniramine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Brompheniramine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Brompheniramine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Brompheniramine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Brompheniramine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Brompheniramine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Brompheniramine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Brompheniramine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Brompheniramine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Brompheniramine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Brompheniramine in the World: Market Share by Brompheniramine Revenue in 2021
Figure 27. Global Brompheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Brompheniramine Sales Market Share by Type (2017-2028)
Figure 29. Global Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 30. Global Brompheniramine Sales Market Share by Application (2017-2028)
Figure 31. Global Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 32. North America Brompheniramine Sales Market Share by Type (2017-2028)
Figure 33. North America Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 34. North America Brompheniramine Sales Market Share by Application (2017-2028)
Figure 35. North America Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 36. North America Brompheniramine Sales Share by Country (2017-2028)
Figure 37. North America Brompheniramine Revenue Share by Country (2017-2028)
Figure 38. United States Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Brompheniramine Sales Market Share by Type (2017-2028)
Figure 41. Europe Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Brompheniramine Sales Market Share by Application (2017-2028)
Figure 43. Europe Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Brompheniramine Sales Share by Country (2017-2028)
Figure 45. Europe Brompheniramine Revenue Share by Country (2017-2028)
Figure 46. Germany Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 47. France Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Brompheniramine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Brompheniramine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Brompheniramine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Brompheniramine Revenue Share by Region (2017-2028)
Figure 57. China Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 60. India Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Brompheniramine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Brompheniramine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Brompheniramine Sales Share by Country (2017-2028)
Figure 71. Latin America Brompheniramine Revenue Share by Country (2017-2028)
Figure 72. Mexico Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Brompheniramine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Brompheniramine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Brompheniramine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Brompheniramine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Brompheniramine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Brompheniramine Revenue Share by Country (2017-2028)
Figure 81. Turkey Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Brompheniramine Revenue (2017-2028) & (US$ Million)
Figure 84. Brompheniramine Value Chain
Figure 85. Brompheniramine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
